Neuphoria Therapeutics Inc. (NEUP) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

42/ 100

GoAI Score

Hold

Valuation

70

Undervalued

Sentiment

48

Mixed

Risk

69

High Risk

Momentum

18

Strong Down

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.

Industry: Biotechnology
Sector: Healthcare
Headquarters: US
CEO: Spyridon Papapetropoulos
Listed since: Dec 16, 2021
Employees: 1

Market position

Day range

Current $3.405

$3.38$3.455

52-week range

Current $3.405

$3.19$19.21

Open: $3.455
Previous close: $3.42
Volume: 1.88K; 0.01× average
Average volume: 144.46K; Average daily volume
Market cap: 18.4M USD
Beta: 0.75; Market reference 1
50-day average: $3.7624; -9.50% below average
200-day average: $4.2133; -19.19% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: -19.85B USD
P/E (TTM): -0.47×
P/B (TTM): 0.75×
P/S (TTM): 15.67×
EV / EBITDA: 2,169.58×
Earnings yield: -70.02%
Free cash flow yield: -64303.69%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 43.54%
Operating margin: -1187.73%
Net margin: -1578.40%
Return on equity: -0.05%
Return on assets: -0.05%
Return on invested capital: -0.03%

Financial health

Debt / equity: 0×
Current ratio: 27.85×
Altman Z-score: -6.13
Piotroski F-score: 1 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

1.17M USD-92.50%

Operating income

−9.81M USD-768.88%

Net income

−13.45M USD-3539.28%

Financial statements: Income statement
Metric (USD)	FY2026	FY2025	FY2024	FY2023	FY2022
Revenue	1.17M USD	15.65M USD	—	—	383.16K USD
Cost of goods sold	662.96K USD	662.89K USD	662.99K USD	671.48K USD	16M USD
Gross profit	511.21K USD	14.99M USD	−662.99K USD	−671.48K USD	−9.98M USD
Research and development	3.55B USD	9.01M USD	14.1M USD	19.67M USD	23.25M USD
Selling, general, and administrative	7.44B USD	7.77M USD	8.47M USD	13.41M USD	7.69M USD
Operating expenses	10.32M USD	16.12M USD	17.89M USD	33.09M USD	23.74M USD
Interest income	665.57K USD	166.5K USD	220.1K USD	486.39K USD	9.87K USD
Interest expense	—	—	—	—	26.87K USD
Depreciation and amortization	662.96K USD	662.89K USD	662.99K USD	970.68K USD	1.11M USD
Operating income	−9.81M USD	−1.13M USD	−26.79M USD	−33.09M USD	−31.02M USD
Net income	−13.45M USD	−369.63K USD	−15.49M USD	−32.18M USD	−22.94M USD

Company facts updated Oct 8, 2026.

Earnings

EPS beat rate: 42%; 5 beats, 5 misses, 2 met estimates
Average EPS surprise: -104.81%; 12 comparable reports
Latest EPS result: -0.56; Estimate -0.56 · Met by 0.00%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

NEUP news

prnewswire.comAug 4, 2026

Are CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Read source

globenewswire.comJul 30, 2026

The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—NRIM, NEUP, SAFT, and RMAX

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a…

Read source

prnewswire.comJul 29, 2026

Are CBZ, SAFT, NEUP Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Read source

globenewswire.comJul 28, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—PBCO, NEUP, SAFT, and PFLC

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a…

Read source

gurufocus.comJul 24, 2026

NEUP Stock Alert: Halper Sadeh LLC is Investigating Whether Neuphoria Therapeutics Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Neuphoria Therapeutics Inc. (NASDAQ: NEUP) and Scancell Holdings plc. Upon closing

Read source